Armata Pharmaceuticals (ARMP) Earnings Date, Estimates & Call Transcripts $2.24 -0.17 (-7.05%) (As of 04:31 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipShort Interest Armata Pharmaceuticals Latest Earnings SummaryLatest Q2 2024 Earnings DateAug. 13EstimatedActual EPS (Aug. 13) -$0.65 Missed By -$0.13 Consensus EPS (Aug. 13) -$0.52 Armata Pharmaceuticals released Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.65, which missed the consensus estimate of -$0.52 by $0.13. With a trailing EPS of -$1.64, Armata Pharmaceuticals' earnings are expected to decrease next year, from ($0.95) to ($1.70) per share. Get Armata Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Armata Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataARMP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ARMP Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Wide Moat ResearchA huge crack is forming in the US economyFormer Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. Armata Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241-$0.52-$0.52-$0.52Q3 20241-$0.28-$0.28-$0.28Q4 20241-$0.35-$0.35-$0.35 Armata Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks8/13/2024Q2 2024-$0.52-$0.65 -$0.13-$1.05--5/7/2024Q1 2024-$0.28-$0.69 -$0.41-$0.69$1.20M$0.97M3/21/2024Q4 2023--$0.55 -$0.55-$0.55$0.68M$1.53M11/14/2023Q3 2023-$0.33-$0.31+$0.02$0.24$0.90M$1.23M8/14/2023Q2 2023-$0.35-$0.28+$0.07-$0.39$1.50M$0.98M5/11/2023Q1 2023-$0.29-$0.40 -$0.11-$0.40$1.50M$0.80M Get the Latest News and Ratings for ARMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Armata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 3/16/2023Q4 2022-$0.25-$0.29 -$0.04-$0.29$1.34M$1.05M Armata Pharmaceuticals Earnings - Frequently Asked Questions When did Armata Pharmaceuticals announce their last quarterly earnings? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) last announced its quarterly earning data on Tuesday, August 13, 2024. Learn more on ARMP's earnings history. Did Armata Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Armata Pharmaceuticals (NYSEAMERICAN:ARMP) missed the analysts' consensus estimate of ($0.52) by $0.13 with a reported earnings per share (EPS) of ($0.65). Learn more on analysts' earnings estimate vs. ARMP's actual earnings. How much revenue does Armata Pharmaceuticals generate each year? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded annual revenue of $4.53 million. How much profit does Armata Pharmaceuticals generate each year? Armata Pharmaceuticals (NYSEAMERICAN:ARMP) has a recorded net income of -$69.04 million. ARMP has generated -$1.64 earnings per share over the last four quarters. What is Armata Pharmaceuticals's EPS forecast for next year? Armata Pharmaceuticals's earnings are expected to decrease from ($0.95) per share to ($1.70) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Northwest Biotherapeutics Earnings Results Design Therapeutics Earnings Results AC Immune Earnings Results Tango Therapeutics Earnings Results Rezolute Earnings Results ProQR Therapeutics Earnings Results Taysha Gene Therapies Earnings Results TScan Therapeutics Earnings Results biote Earnings Results Poseida Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report A huge crack is forming in the US economy (Ad)Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”Learn how to protect yourself too, click here. This page (NYSEAMERICAN:ARMP) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredThis “IRS Loophole” Allows You to Do WHAT?Little-Known IRS Loophole Beats Inflation 4x Over New guide reveals how to take advantage of this federally...Gold Safe Exchange | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Armata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Armata Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARMP Stock Alerts